United European Gastroenterology Journal

Papers
(The H4-Index of United European Gastroenterology Journal is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
148
Table of Contents140
UEG Week 2023 Oral Presentations113
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers104
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature90
Medical guidelines must not be influenced by commercial interests88
Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”79
UEG's prospects for the future47
Stunned by a stone—A curious case of belly trouble45
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response44
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study44
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era44
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 201843
Letter of Thanks for UEG Week 2022 Reviewers41
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis40
Shedding a new light on gastric cancer screening39
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps38
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ38
Recent developments in the management of ascites in cirrhosis38
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study36
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management36
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study35
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?34
Issue Information33
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”32
 32
31
Primary malignant melanoma of the oesophagus30
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?30
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?29
0.03475022315979